CN105168952A - Compound maca health care product - Google Patents
Compound maca health care product Download PDFInfo
- Publication number
- CN105168952A CN105168952A CN201510433721.6A CN201510433721A CN105168952A CN 105168952 A CN105168952 A CN 105168952A CN 201510433721 A CN201510433721 A CN 201510433721A CN 105168952 A CN105168952 A CN 105168952A
- Authority
- CN
- China
- Prior art keywords
- meyenii walp
- lepidinm meyenii
- parts
- health product
- compound recipe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a health care product, in particular to a compound maca health care product, which is characterized by mainly being formed by mixing the following ingredients in parts by weight: 20 to 70 parts of maca, 15 to 25 parts of black fruit Chinese wolfberries, 2 to 20 parts of herba dendrobii and 3 to 15 parts of herba cistanches. The composition has the advantages that four ingredients supplement each other; and the synergistic effects on enhancing the fertility, improving the immunity, delaying the human body senescence, resisting fatigue, treating the neurasthenia and lowering the blood pressure are achieved.
Description
Technical field
The present invention relates to health product, particularly relate to a kind of compound recipe Lepidinm meyenii Walp health product.
Background technology
Lepidinm meyenii Walp is a kind of plant of Cruciferae separate row Vegetable spp, originates in mountain area, Peru Andean, locals mainly with it as food, also as conventional medicament use, introduce a fine variety in a large number in Yunnan Province at present.Lepidinm meyenii Walp has resisting fatigue, improvement function, improves the several functions such as fertility.By zoopery and human experimentation research, demonstrate it and there is resisting fatigue, improvement function, antioxidation, minimizing prostatic hyperplasia really, improve the effects such as fertility.
Lycium ruthenicum Murr., be the perennial shrub of Lycium section, Lycium ruthenicum Murr. contains 17 seed amino acids, 13 kinds of trace element, and wherein the content of calcium, magnesium, copper, zinc, ferrum is also higher than red Fructus Lycii.It is the most effective natural free radical scavenger that wild Lycium ruthenicum Murr. contains a large amount of anthocyanin elements, and delaying human body cell tissue is old and feeble.Keep younger state, life lengthening.It is medicinal, and health value is far away higher than common red Fructus Lycii.Be described as " soft gold ".Drink with wild Lycium ruthenicum Murr. bubble for a long time, tool obviously protects vision protection effect, prevents and treats diabetes effect preferably in addition.There is obvious resisting fatigue, protect the liver, antitumor, dredging vascellum, blood pressure lowering, protection Cardiovascular System.
Herba Dendrobii, medicinal history is long, and medicinal ingredient is not only abundant but also balanced, can treat multiple illness, is used for treatment chronic pharyngitis, gastroenteropathy, ophthalmic diseases clinically, the treatment of thrombosis, diabetes, arthritis, cancer or auxiliary treatment.Particularly in recent years for eliminating the side effect after cancer radiation, chemotherapy and recovering physical ability, effect is fairly obvious.Defying age, improves immunity, blood circulation promoting and blood stasis dispelling, improves cardio and vascular function, antitumor, treatment digestive system disease, treatment ophthalmic diseases.
Herba Cistanches, Herba Cistanches is used as medicine, long-standing.It is sweet and warm in nature, and salty and matter profit, has YANG invigorating not dry, and the logical kidney yang the kidney invigorating of temperature is empty; Nourishing YIN is oiliness, and the feature that abdomen treats constipation is led in intestine moistening.Asthenia internal injury controlled by Chinese medicine, chills and pain of the waist and kness, sexual impotence, and spermatorrhea is infertile, the empty constipation of body.In recent years, the world of medicine's application modern scientific method carries out assay to Herba Cistanches, result shows, Herba Cistanches contains Alkaloid and crystallinity neutral substance, truly have effect for the treatment of chills and pain of the waist and kness, woman infertility, neurasthenia, auditory dysesthesia, also there is the effect reduced blood pressure, and can be used as the hemorrhage use of cystitis, bladder hemorrhage, kidney hemorrhagic disease.
Current above-mentioned various raw material all has folk prescription or the finished product processed with other raw material compound recipe or patent, and dosage form has tablet, but has no the product and reported in literature that are made up of above four kinds of raw materials.
Summary of the invention
The object of this invention is to provide a kind of compound recipe Lepidinm meyenii Walp health product, it is characterized in that, be mainly grouped into by the one-tenth of following weight portion: Lepidinm meyenii Walp 20-70 part, Lycium ruthenicum Murr. 15-25 part, Herba Dendrobii 2-20 part, Herba Cistanches 3-15 part are obtained by mixing.
Further, be grouped into by the one-tenth of following weight portion: Lepidinm meyenii Walp 35-50 part, Lycium ruthenicum Murr. 17-22 part, Herba Dendrobii 5-16 part, Herba Cistanches 6-12 part are obtained by mixing.
Further, also comprise probiotic bacteria, account for 60-90 part by weight.
Further, also comprise probiotic bacteria, account for 70-80 part by weight.
Further, described compositions also comprises inulin, starch, oligomeric xylose or cellulose.
Further, described compositions may be used for preparing electuary, capsule, oral liquid or tablet.
Compositions of the present invention is that the functional characteristics respectively had according to Lepidinm meyenii Walp, Lycium ruthenicum Murr., Herba Dendrobii and Herba Cistanches carries out matched combined, and Lepidinm meyenii Walp has resisting fatigue, improvement function, antioxidation, minimizing prostatic hyperplasia, improves the effects such as fertility; Lycium ruthenicum Murr. has delaying human body cell ageing, has obvious resisting fatigue, protects the liver, antitumor, dredging vascellum, blood pressure lowering, protection Cardiovascular System; Herba Dendrobii has defying age, improves immunity, blood circulation promoting and blood stasis dispelling, improves cardio and vascular function, antitumor; Herba Cistanches has effect for the treatment of chills and pain of the waist and kness, woman infertility, neurasthenia, auditory dysesthesia, also there is the effect reduced blood pressure, four supplement and complement each other, for enhancing fertility, improve immunity, delaying human body caducity, resisting fatigue, treatment neurasthenia, reducing blood pressure has synergism.
Detailed description of the invention
Technical scheme of the present invention is described in detail below in conjunction with embodiment.
Embodiment 1:
A kind of compound recipe Lepidinm meyenii Walp health product, comprise Lepidinm meyenii Walp, Lycium ruthenicum Murr., Herba Dendrobii and Herba Cistanches, the weight of various component: Lepidinm meyenii Walp 70 parts, Lycium ruthenicum Murr. 15 parts, Herba Dendrobii 12 parts, Herba Cistanches 3 parts are obtained by mixing.Lepidinm meyenii Walp, Lycium ruthenicum Murr., Herba Dendrobii and Herba Cistanches can be all crude drug or the compositions for extract.Described extract extracts by the method for prior art with crude drug and obtains.
Embodiment 2:
A kind of compound recipe Lepidinm meyenii Walp health product, comprise Lepidinm meyenii Walp, Lycium ruthenicum Murr., Herba Dendrobii and Herba Cistanches, the weight of various component: Lepidinm meyenii Walp 20 parts, Lycium ruthenicum Murr. 25 parts, Herba Dendrobii 20 parts, Herba Cistanches 15 parts are obtained by mixing.All the other conditions are identical with embodiment 1.
Embodiment 3:
A kind of compound recipe Lepidinm meyenii Walp health product, comprise Lepidinm meyenii Walp, Lycium ruthenicum Murr., Herba Dendrobii and Herba Cistanches, the weight of various component: Lepidinm meyenii Walp 50 parts, Lycium ruthenicum Murr. 22 parts, Herba Dendrobii 12 parts, Herba Cistanches 6 parts.All the other conditions are identical with embodiment 1.
Embodiment 4:
A kind of compound recipe Lepidinm meyenii Walp health product, comprise Lepidinm meyenii Walp, Lycium ruthenicum Murr., Herba Dendrobii and Herba Cistanches, the weight of various component: Lepidinm meyenii Walp 35 parts, Lycium ruthenicum Murr. 17 parts, Herba Dendrobii 16 parts, Herba Cistanches 7 parts.All the other conditions are identical with embodiment 1.
Embodiment 5:
A kind of compound recipe Lepidinm meyenii Walp health product, comprise Lepidinm meyenii Walp, Lycium ruthenicum Murr., Herba Dendrobii, Herba Cistanches, probiotic bacteria, the weight of various component: Lepidinm meyenii Walp 35 parts, Lycium ruthenicum Murr. 22 parts, Herba Dendrobii 16 parts, Herba Cistanches 7 parts, probiotic bacteria 60 parts.All the other conditions are identical with embodiment 1.
Embodiment 6:
A kind of compound recipe Lepidinm meyenii Walp health product, comprise Lepidinm meyenii Walp, Lycium ruthenicum Murr., Herba Dendrobii, Herba Cistanches, probiotic bacteria, the weight of various component: Lepidinm meyenii Walp 35 parts, Lycium ruthenicum Murr. 22 parts, Herba Dendrobii 6 parts, Herba Cistanches 7 parts, probiotic bacteria 90 parts.All the other conditions are identical with embodiment 1.
Embodiment 7:
A kind of compound recipe Lepidinm meyenii Walp health product, comprise Lepidinm meyenii Walp, Lycium ruthenicum Murr., Herba Dendrobii, Herba Cistanches, probiotic bacteria, the weight of various component: Lepidinm meyenii Walp 35 parts, Lycium ruthenicum Murr. 22 parts, Herba Dendrobii 16 parts, Herba Cistanches 7 parts, probiotic bacteria 70 parts.All the other conditions are identical with embodiment 1.
Embodiment 8:
A kind of compound recipe Lepidinm meyenii Walp health product, comprise Lepidinm meyenii Walp, Lycium ruthenicum Murr., Herba Dendrobii, Herba Cistanches, probiotic bacteria, the weight of various component: Lepidinm meyenii Walp 35 parts, Lycium ruthenicum Murr. 22 parts, Herba Dendrobii 6 parts, Herba Cistanches 7 parts, probiotic bacteria 80 parts.All the other conditions are identical with embodiment 1.
Below the Application Example of said composition, when compositions be crude drug or solid extract time, first pulverize, cross after 50 mesh sieves and prepare burden again.
Embodiment 9:
The preparation of compound recipe Lepidinm meyenii Walp troche of health products: Lepidinm meyenii Walp, Lycium ruthenicum Murr., Herba Dendrobii and Herba Cistanches compositions 80%, starch 5%, cellulose 15% drop into mixing 10-30 minute in mixer, add ethanol as wetting agent, mixing 10-30 minute, mixed material 12-20 mesh sieve is granulated, and puts into drying equipment inner drying, adds 1% magnesium stearate (or in prior art conventional amount used) of dried particles total amount, granulate, tabletting, packaging, namely makes tablet of the present invention.
Embodiment 10:
The preparation of compound recipe Lepidinm meyenii Walp troche of health products: Lepidinm meyenii Walp, Lycium ruthenicum Murr., Herba Dendrobii, Herba Cistanches, Herba Leonuri bacteria composition 70%, starch 10%, cellulose 20%, following steps are with embodiment 9.
Embodiment 11:
The preparation of compound recipe Lepidinm meyenii Walp health product capsule: Lepidinm meyenii Walp, Lycium ruthenicum Murr., Herba Dendrobii and Herba Cistanches compositions 50%, starch 50%, drops into mixing 10-30 minute in mixer, adds ethanol as wetting agent, mixing 5-10 minute, mixed material 12-20 mesh sieve is granulated, and puts into drying equipment inner drying, adds 1% magnesium stearate (or in prior art conventional amount used) of dried particles total amount, granulate, capsule charge, packaging, namely making content is heavily the capsule of 0.3g.
The additive of above-mentioned compound recipe Lepidinm meyenii Walp health product is starch, as being preferably one or more combination thing in inulin, oligomeric xylose or cellulose.
Embodiment 12:
The preparation of electuary: Lepidinm meyenii Walp, Lycium ruthenicum Murr., Herba Dendrobii and Herba Cistanches compositions 10%, add 80% dextrin, 10% white sugar, (compositions and white sugar are pulverized, crossed 80 mesh sieves), drops into mixing 10-30 minute in mixer, adds ethanol as wetting agent, mixing 5-10 minute, mixed material 12-20 mesh sieve is granulated, and puts into drying equipment inner drying, dry with the screening of 10-60 eye mesh screen, pack after removing coarse granule and fine powder, be packaged into every bag of 3g.
Embodiment 13:
The preparation of oral liquid: Lepidinm meyenii Walp, Lycium ruthenicum Murr., Herba Dendrobii and Herba Cistanches compositions, add 5 times amount purified water and obtain oral liquid, add the potassium sorbate (or in prior art conventional amount used) of oral liquid measure 0.1%, filtration, subpackage, sterilizing, packaging, obtain oral liquid of the present invention.
In sum, described health composition can be used for preparing tablet, capsule, electuary, oral liquid.
Embodiment 14:
Experimental conditions is as follows:
(1) compound recipe Lepidinm meyenii Walp health product (embodiment 4) impact on mice muscle power:
Only choose Male Kunming strain mice 20-24g40, be divided at random 4 groups (often organizing 10 mices), wherein establish normal saline negative control group and 3 compound recipe Lepidinm meyenii Walp health product various dose groups of the present invention, little, in, the extract of large three dosage component gavage compound recipe other every day Lepidinm meyenii Walp health product, dosage is respectively 0.5g/kg, 1.0g/kg, 1.5g/kg, successive administration 40d, carries out mice heavy burden test after last gavage 30min.Mouse tail is born a heavy burden 5%, is placed in 100cm × 80cm × 40cm pond went swimming, depth of water 30cm, water temperature 25 DEG C ± 0.5 DEG C, 10, every pond mice, record mice swimming beginning is the mice burden swimming time to the death time.Experiment shows, 1.0g/kg, 1.5g/kg group can obviously extend the mice burden swimming time, compares have significance (P < 0.01) with negative group.The results are shown in Table 1.
Table 1 physical exertion is tested
| Group | Dosage (g/Kg) | Swimming time (S) |
| Negative control group | Normal saline | 320.5±126.4 |
| Small dose group | 0.5 | 397.8±174.9 |
| Middle dosage group | 1.0 | 582.3±216.9 |
| Heavy dose of group | 1.5 | 653.2±284.3 |
(2) compound recipe Lepidinm meyenii Walp health product (embodiment 13) impact on white mice immunity.Get 615 inbred line Kunming kind female mice 36.After weighing, get body weight the mice of 20-24 gram, be divided into 12 groups at random, often organize 3, make weight differences between each group not remarkable.Then being put on 12 positions at random, random extracting 4 groups out as drinking group (I), extract 4 groups afterwards more at random out as injection group (II), remaining 4 groups as a control group (III), environment zero difference can be made like this.Drink group mice and often only drink 1ml compound recipe Lepidinm meyenii Walp health product solution every day, injection group mice lumbar injection every day 0.1ml compound recipe Lepidinm meyenii Walp health product solution, 4:00 drank and injected compound recipe Lepidinm meyenii Walp health product solution to mice every afternoon.Experimental period is 30 days.Experimental session, mice ad lib and drinking-water.
Test after 40 days, start immunity test experiments immediately, mice peripheral T lymphocyte enzyme labelling staining (affecting the experimental technique of cellular immune function), interpretation is as follows, the results are shown in Table 2, after drinking these compound recipe Lepidinm meyenii Walp health product to mice, the percentage rate shared by T lymphocyte significantly improves, drink group and the poor heteropole of matched group remarkable (P≤0.01), illustrate that oral administered compound Lepidinm meyenii Walp health product can obviously promote mouse cell immunologic function.Injection group and matched group comparing difference also extremely significantly (P≤0.01), illustrate that injection compound recipe Lepidinm meyenii Walp health product also can promote mouse cell immunologic function.
Table 2 compound recipe Lepidinm meyenii Walp health product are on the impact of mouse T lymphocyte percentage composition
| Group | Mus number (only) | Dosage (ml/ only) | T lymphocyte percentage % (% ± Sd) |
| I | 12 | 1 | 67.905±2.937 |
| II | 12 | 0.1 | 67.169±1.995 |
| III | 12 | 0 | 61.103±2.149 |
(3) compound recipe Lepidinm meyenii Walp health product (embodiment 4) impact on Normal male mice mating ability
Male mice prepares: get body weight 18 ~ 22g male mice 60, be divided into 5 groups at random, often organizes 12.Normal group, every day gavage equal-volume normal saline; Methyl testosterone group, every day gavage 1mg/kg; Health product of the present invention are large, medium and small three dosage groups, respectively gavage every day health product 0.5g/kg, 1.0g/kg, 1.5g/kg of the present invention.Successive administration 15 days.
Female mice prepares: the female mice getting 60 body weight 35 ~ 40g, 30mg/kg pentobarbital intraperitoneal injection of anesthesia, carries out bilateral ovaries enucleation.Within postoperative 2nd day, can test.Before experiment, subcutaneous injection estradiol 20 μ g/ only, starts experiment after 48 hours.Only Progesterone 500 μ g/ was injected again before 4 hours.
Mating test: first male mice is put into separately cage before copulation starts and to conform 5min, then put into 1 female Mus, start to record and flutter the time (ejaculation latency) of catching female Mus time (flutter and catch incubation period) and being fed into the 1st ejaculation of male Mus from female Mus for the 1st time from male Mus; In 20min, male Mus flutters the several and ejaculation frequency of catching female Mus.Experimental result shows, compare with Normal group, methyl testosterone and little, the middle and high dosage group of health product of the present invention all shorten mice and flutter and catch incubation period and increase and flutter and catch number of times (methyl testosterone group and heavy dose of group P < 0.01, little, middle dosage group P < 0.05); Methyl testosterone group, middle dosage group and heavy dose of group all shorten mice ejaculation latency and increase ejaculation frequency (methyl testosterone group and heavy dose of group P < 0.01, middle dosage group P < 0.05).The results are shown in Table 3.
Table 3
Claims (6)
1. compound recipe Lepidinm meyenii Walp health product, is characterized in that, are mainly grouped into by the one-tenth of following weight portion: Lepidinm meyenii Walp 20-70 part, Lycium ruthenicum Murr. 15-25 part, Herba Dendrobii 2-20 part, Herba Cistanches 3-15 part are obtained by mixing.
2. a kind of compound recipe Lepidinm meyenii Walp health product according to claim 1, is characterized in that, are be grouped into by the one-tenth of following weight portion: Lepidinm meyenii Walp 35-50 part, Lycium ruthenicum Murr. 17-22 part, Herba Dendrobii 5-16 part, Herba Cistanches 6-12 part are obtained by mixing.
3. a kind of compound recipe Lepidinm meyenii Walp health product according to claim 1, is characterized in that, also comprise probiotic bacteria, account for 60-90 part by weight.
4. a kind of compound recipe Lepidinm meyenii Walp health product according to claim 1, is characterized in that, also comprise probiotic bacteria, account for 70-80 part by weight.
5. a kind of compound recipe Lepidinm meyenii Walp health product according to claim 1 or 3, is characterized in that, also comprise inulin, starch, oligomeric xylose or cellulose.
6. a kind of compound recipe Lepidinm meyenii Walp health product according to claim 1 or 2 or 3 or 4, is characterized in that: described compound may be used for preparing electuary, capsule, oral liquid or tablet.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510433721.6A CN105168952A (en) | 2015-07-23 | 2015-07-23 | Compound maca health care product |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510433721.6A CN105168952A (en) | 2015-07-23 | 2015-07-23 | Compound maca health care product |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105168952A true CN105168952A (en) | 2015-12-23 |
Family
ID=54891702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510433721.6A Pending CN105168952A (en) | 2015-07-23 | 2015-07-23 | Compound maca health care product |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105168952A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112385757A (en) * | 2019-08-16 | 2021-02-23 | 肖珍兵 | Maca composite beverage and preparation method thereof |
-
2015
- 2015-07-23 CN CN201510433721.6A patent/CN105168952A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112385757A (en) * | 2019-08-16 | 2021-02-23 | 肖珍兵 | Maca composite beverage and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102716263B (en) | Maca, ginseng and medlar composition and application thereof | |
| CN103859412B (en) | Health-care food for male and preparation method thereof | |
| CN108523122A (en) | A kind of weight losing meal-replacing powder | |
| CN105054007A (en) | Health-care moringa seed product | |
| CN102813779A (en) | Novel traditional Chinese medicine composition and preparation method and application thereof | |
| CN103549433A (en) | Traditional Chinese medicine health-care food with liver protecting effect | |
| CN102813693A (en) | Novel composite and preparation method and application thereof | |
| CN106343343A (en) | Lithocarpus polystachyus (DC.) Rehd tartarian buckwheat composition for reducing three-high and application thereof | |
| CN103830628A (en) | Traditional Chinese medicine feed additive for preventing and treating piglet diarrhea and preparation method thereof | |
| CN103349121B (en) | Hyperglycemia-hyperlipidemia-hypertension relieving health protection tea and preparation method thereof | |
| KR102042798B1 (en) | A method for preparing functional pills comprising extracts of natural materials | |
| CN105168566A (en) | Health care composition | |
| CN105168567A (en) | Maca health care composition | |
| KR20160000695A (en) | Herbal-medicine containing dha for recovering fatigue and enhancing memory, and method of manufacturing the same | |
| CN105998938A (en) | Feed additive for treating bacterial red skin disease of tilapia mossambica and preparation method therefor | |
| CN105168564A (en) | Moringa seed health care composition | |
| CN105941879A (en) | Feed for mutton sheep | |
| CN106360066A (en) | Turkey feed | |
| CN105029413A (en) | Maca health care composition | |
| CN105168953A (en) | Maca multifunctional health care product | |
| CN105168952A (en) | Compound maca health care product | |
| KR101783549B1 (en) | Health supplement food containing dha for recovering fatigue, and method of manufacturing the same | |
| CN104382148A (en) | Fruit and vegetable drink beneficial to improving male vigour | |
| CN106721248A (en) | A kind of special feed for weanling pig | |
| CN105168954A (en) | Health care composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20151223 |